Robin L. Washington
2013
In 2013, Robin L. Washington earned a total compensation of $3.9M as Executive Vice President and Chief Financial Officer at Gilead Sciences, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $787,500 |
|---|---|
| Option Awards | $1,196,249 |
| Salary | $746,219 |
| Stock Awards | $1,203,270 |
| Other | $8,490 |
| Total | $3,941,728 |
Washington received $1.2M in stock awards, accounting for 31% of the total pay in 2013.
Washington also received $787.5K in non-equity incentive plan, $1.2M in option awards, $746.2K in salary and $8.5K in other compensation.
Rankings
In 2013, Robin L. Washington's compensation ranked 1,796th out of 12,286 executives tracked by ExecPay. In other words, Washington earned more than 85.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,796 out of 12,286 | 85th |
Division Manufacturing | 583 out of 4,612 | 87th |
Major group Chemicals And Allied Products | 157 out of 1,466 | 89th |
Industry group Drugs | 106 out of 1,160 | 91st |
Industry Biological Products, Except Diagnostic Substances | 12 out of 200 | 94th |
Source: SEC filing on March 28, 2016.
Washington's colleagues
We found four more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2013.